PD-1/PD-L1 blockade as part of combination strategies toward functional cure of chronic hepatitis B - Top-Institutions - MDSpire

PD-1/PD-L1 blockade as part of combination strategies toward functional cure of chronic hepatitis B

  • By

  • Mei Li

  • Dandan Feng

  • Juanjuan Shi

  • Shuangsuo Dang

  • Xiaoli Jia

  • Wenjun Wang

  • July 9, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, Massachusetts

    Key Differentiators

    • Hepatology
    • Gastroenterology

  • #2

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Hepatology
    • Immunology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Hepatology
    • Transplantation

  • #4

    University of California Los Angeles
    University of California Los Angeles

    Los Angeles, California

    Key Differentiators

    • Hepatology
    • Gastroenterology

  • #5

    American Association for the Study of Liver Diseases
    American Association for the Study of Liver Diseases

    Alexandria, Virginia

    Key Differentiators

    • Hepatology

Original Source(s)

PD-1/PD-L1 blockade as part of combination strategies toward functional cure of chronic hepatitis B

  • by Mei Li, Dandan Feng, Juanjuan Shi, Shuangsuo Dang, Xiaoli Jia, Wenjun Wang

  • July 9, 2026

Related Content

SIMPL data, complex procedures: a national analysis of chief resident competency in foregut and bariatric surgery

Osteoarthritis as a systemic disorder: multi-organ crosstalk in pathogenesis and therapeutic targeting

RHOA at the intersection of inflammation-driven and sporadic colorectal cancer